MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Revenue
$60,112K
Net Income
-$56,743K
Net Profit Margin
-94.40%
EPS
-$0.83
Unit: Thousand (K) dollars
Revenue Breakdown
    • US
    • Non Us
Revenue Breakdown
    • US
    • Non Us
Revenue Breakdown
    • US
    • Non Us
Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Total revenues
60,112
57,253
51,298
48,502
Cost of sales
7,157
4,802
5,499
5,543
Research and development
41,725
42,032
46,027
42,308
Selling, general, and administrative
63,591
57,482
52,425
45,947
Total costs and expenses
112,473
104,316
103,951
93,798
Loss from operations
-52,361
-47,063
-52,653
-45,296
Other income (expense), net
-1,704
58
274
1,576
Gain on settlement of forward contract
-
0
-
-
Interest expense
4,583
4,615
4,742
5,817
Interest income
3,554
4,084
4,328
3,242
Total other income (expense), net
-2,733
-473
-140
-999
Loss before income taxes
-55,094
-47,536
-52,793
-46,295
Provision for income taxes
545
-31
111
337
Net loss
-55,639
-47,505
-52,904
-46,632
Accrued dividends on convertible preferred stock
1,104
1,332
1,375
1,349
Net loss
-56,743
-48,837
-54,279
-47,981
Foreign currency translation adjustment
-
-883*
-
-
Unrealized (loss) gain, net on marketable securities, net of tax
-
126*
-
-
Comprehensive loss
-
-49,594
-
-
Basic EPS
-0.83
-0.741
-0.82
-0.75
Diluted EPS
-0.83
-0.741
-0.82
-0.75
Basic Average Shares
67,974,193
66,932,865
66,261,055
63,684,359
Diluted Average Shares
67,974,193
66,932,865
66,261,055
63,684,359
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

US$36,896K (51.41%↑ Y/Y)Non Us$23,216K (73.92%↑ Y/Y)Net loss-$56,743K (-11.65%↓ Y/Y)Revenue From ContractWith Customer...$60,112K (59.37%↑ Y/Y)Net loss-$55,639K (-12.41%↓ Y/Y)Accrued dividends onconvertible preferred stock$1,104K (-16.49%↓ Y/Y)Revenue From ContractWith Customer...$60,112K (59.37%↑ Y/Y)Loss before incometaxes-$55,094K (-11.49%↓ Y/Y)Provision for income taxes$545K (581.25%↑ Y/Y)Product$60,112K Loss from operations-$52,361K (-11.40%↓ Y/Y)Total other income(expense), net-$2,733K (-13.21%↓ Y/Y)Total revenues$60,112K (83.81%↑ Y/Y)Interest income$3,554K (-2.34%↓ Y/Y)Total costs andexpenses$112,473K (41.11%↑ Y/Y)Interest expense$4,583K (-15.27%↓ Y/Y)Other income(expense), net-$1,704K (-164.60%↓ Y/Y)Selling, general, andadministrative$63,591K (62.69%↑ Y/Y)Research and development$41,725K (12.85%↑ Y/Y)Cost of sales$7,157K (96.19%↑ Y/Y)

RHYTHM PHARMACEUTICALS, INC. (RYTM)

RHYTHM PHARMACEUTICALS, INC. (RYTM)